Pages that link to "Q33556647"
Jump to navigation
Jump to search
The following pages link to Cisplatin-resistant cells express increased levels of a factor that recognizes damaged DNA. (Q33556647):
Displaying 50 items.
- UV-damaged DNA-binding proteins are targets of CUL-4A-mediated ubiquitination and degradation (Q24291831) (← links)
- Mutations specific to the xeroderma pigmentosum group E Ddb- phenotype (Q24322600) (← links)
- Physical interaction of tumour suppressor p53/p73 with CCAAT-binding transcription factor 2 (CTF2) and differential regulation of human high-mobility group 1 (HMG1) gene expression (Q24529877) (← links)
- Correction of the DNA repair defect in xeroderma pigmentosum group E by injection of a DNA damage-binding protein (Q24563372) (← links)
- Mechanisms of resistance to alkylating agents (Q24596948) (← links)
- A gene expression signature of acquired chemoresistance to cisplatin and fluorouracil combination chemotherapy in gastric cancer patients (Q28477202) (← links)
- Damaged DNA-binding protein 2 (DDB2) protects against UV irradiation in human cells and Drosophila (Q33828372) (← links)
- Restoration of UV sensitivity in UV-resistant HeLa cells by antisense-mediated depletion of damaged DNA-binding protein 2 (DDB2). (Q34114799) (← links)
- Recognition of cisplatin adducts by cellular proteins (Q34282236) (← links)
- Rapid changes of nucleotide excision repair gene expression following UV-irradiation and cisplatin treatment of Dictyostelium discoideum (Q34671374) (← links)
- A 127 kDa component of a UV-damaged DNA-binding complex, which is defective in some xeroderma pigmentosum group E patients, is homologous to a slime mold protein (Q34999430) (← links)
- Involvement of the Ku autoantigen in the cellular response to DNA double-strand breaks (Q35652566) (← links)
- Modulation of cis-diamminedichloroplatinum(II) resistance: a review (Q35707858) (← links)
- Ca2+-mediated inhibition of a nuclear protein that recognizes UV-damaged DNA and is constitutively overexpressed in resistant human cells: DNA-binding assay (Q35795356) (← links)
- An ultraviolet light-damaged DNA recognition protein absent in xeroderma pigmentosum group E cells binds selectively to pyrimidine (6-4) pyrimidone photoproducts (Q35933800) (← links)
- Cisplatin-DNA damage recognition proteins in human tumour extracts (Q35976534) (← links)
- Characterisation of high-level cisplatin-resistant cell lines established from a human hepatoma cell line and human KB adenocarcinoma cells: cross-resistance and protein changes (Q36080744) (← links)
- A DNA end-binding factor involved in double-strand break repair and V(D)J recombination (Q36657203) (← links)
- Cross-resistance to UV radiation of a cisplatin-resistant human cell line: overexpression of cellular factors that recognize UV-modified DNA (Q36688531) (← links)
- Oxaliplatin in the treatment of colorectal cancer (Q36788436) (← links)
- Photoaffinity isolation and identification of proteins in cancer cell extracts that bind to platinum-modified DNA. (Q37261476) (← links)
- Evidence for a novel DNA damage binding protein in human cells (Q37475317) (← links)
- A novel role for DNA photolyase: binding to DNA damaged by drugs is associated with enhanced cytotoxicity in Saccharomyces cerevisiae (Q38301768) (← links)
- Purification of a HeLa cell nuclear protein that binds selectively to DNA irradiated with ultra-violet light (Q38317444) (← links)
- Differential expression of pyrimidine dimer-binding proteins in normal and UV light-treated vertebrate cells (Q38320252) (← links)
- Identification of Small Molecule Translesion Synthesis Inhibitors That Target the Rev1-CT/RIR Protein-Protein Interaction (Q38679334) (← links)
- Electrophoretic mobility shift assays for protein-DNA complexes involved in DNA repair (Q39286672) (← links)
- p48 Activates a UV-damaged-DNA binding factor and is defective in xeroderma pigmentosum group E cells that lack binding activity (Q39575414) (← links)
- Evaluating the molecule-based prediction of clinical drug responses in cancer (Q39646838) (← links)
- Acquisition of chemoresistance following discontinuous exposures to cisplatin is associated in ovarian carcinoma cells with progressive alteration of FAK, ERK and p38 activation in response to treatment (Q40334868) (← links)
- Cellular resistance to cancer chemotherapy. (Q40596146) (← links)
- Platinum resistance. Experimental and clinical status. (Q40677469) (← links)
- Apaf-1 overexpression partially overcomes apoptotic resistance in a cisplatin-selected HeLa cell line (Q40779227) (← links)
- Genomic imbalances associated with acquired resistance to platinum analogues (Q40807070) (← links)
- Mechanisms of drug resistance in ovarian cancer (Q40869292) (← links)
- Tyrosinase-related protein 2 as a mediator of melanoma specific resistance to cis-diamminedichloroplatinum(II): therapeutic implications (Q40902829) (← links)
- Role of DNA repair in the mechanisms of cell resistance to alkylating agents and cisplatin (Q40903245) (← links)
- Enhancement of excision repair of cisplatin-DNA adducts by cell-free extract from a cisplatin-resistant rat cell line (Q40951206) (← links)
- Induction, not associated with host-cell re-activation of damaged plasmid DNA, of damaged-DNA-recognition proteins by retinoic acid and dibutyryl cyclic AMP in mammalian cells (Q41239100) (← links)
- Inhibition of cis‐diamminedichloroplatinum (II)‐induced DNA interstrand cross‐link removal by 7‐ethyl‐10‐hydroxy‐camptothecin in HST‐1 human squamous‐carcinoma cells (Q41327088) (← links)
- Lack of DNA enzymatic photoreactivation in HeLa cell-free extracts (Q41508012) (← links)
- Constitutive over-production of DNA-damage recognition proteins and acquired UV resistance in prolonged culture of F9 teratocarcinoma stem cells (Q41533069) (← links)
- Reduction of cellular cisplatin resistance by hyperthermia—a review (Q41631033) (← links)
- Detection of proteins that recognize platinum-modified DNA using gel mobility shift assay (Q41712964) (← links)
- Damage-recognition proteins as a potential indicator of DNA-damage-mediated sensitivity or resistance of human cells to ultraviolet radiation (Q41791031) (← links)
- Identification of inducible damage-recognition proteins that are overexpressed in HeLa cells resistant to cis-diamminedichloroplatinum (II). (Q41881603) (← links)
- Up-regulation of FLIP in cisplatin-selected HeLa cells causes cross-resistance to CD95/Fas death signalling (Q42268479) (← links)
- Differentially expressed genes associated with CIS-diamminedichloroplatinum (II) resistance in head and neck cancer using differential display and CDNA microarray (Q44323823) (← links)
- Molecular and cellular effects of ultraviolet light-induced genotoxicity (Q47849891) (← links)
- Binding of the Escherichia coli UvrAB proteins to the DNA mono- and diadducts of cis-[N-2-amino-N-2-methylamino-2,2,1-bicycloheptane]dichloroplatinum(II ) and cisplatin. Analysis of the factors controlling recognition and proof of monoadduct-mediate (Q54604072) (← links)